(Q51500381)

6 April 2018

title

Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia. (English)

1 reference

6 April 2018

0 references

1 reference

3

1 reference

6 April 2018

author name string

Ren-Rong Wu

1

1 reference

6 April 2018

Jing-Ping Zhao

2

1 reference

6 April 2018

Jin-Guo Zhai

4

1 reference

6 April 2018

Xiao-Feng Guo

5

1 reference

6 April 2018

Wen-Bing Guo

6

1 reference

6 April 2018

Jing-Song Tang

7

1 reference

6 April 2018

publication date

7 April 2006

1 reference

6 April 2018

published in

Psychopharmacology

1 reference

6 April 2018

volume

186

1 reference

6 April 2018

issue

4

1 reference

6 April 2018

page(s)

572-578

1 reference

6 April 2018

https://scigraph.springernature.com/pub.10.1007/s00213-006-0384-5

exact match

0 references

cites work

Interventions for Weight Gain in Adults Treated With Novel Antipsychotics

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-006-0384-5

Development of the multiple metabolic syndrome: an epidemiologic perspective

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-006-0384-5

A crossover study on lipid and weight changes associated with olanzapine and risperidone

21 January 2018

1 reference

12 December 2020

Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients

1 reference

12 December 2020

Severe hyperglycemia associated with high doses of clozapine

1 reference

12 December 2020

Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolism

1 reference

12 December 2020

Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder

1 reference

12 December 2020

Induction of obesity by psychotropic drugs

1 reference

12 December 2020

Antipsychotic medication and diabetes mellitus

1 reference

12 December 2020

Hyperglycemic properties of serotonin receptor antagonists

1 reference

12 December 2020

Weight Change after an Atypical Antipsychotic Switch

1 reference

12 December 2020

Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.

1 reference

12 December 2020

Disturbed glucose metabolism among patients taking olanzapine and typical antipsychotics

1 reference

12 December 2020

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

12 December 2020

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics

1 reference

12 December 2020

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

1 reference

12 December 2020

Atypical antipsychotics and glucose homeostasis.

1 reference

12 December 2020

The increase in risk of diabetes mellitus from exposure to second-generation antipsychotic agents.

1 reference

12 December 2020

The effect of clozapine on factors controlling glucose homeostasis

1 reference

12 December 2020

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

12 December 2020

The homeostasis model in the San Antonio Heart Study.

1 reference

12 December 2020

Correlation of serum ghrelin levels with body mass index and carbohydrate metabolism in patients treated with atypical antipsychotics.

1 reference

12 December 2020

Actions of antipsychotic drugs on pancreatic beta-cell function: contrasting effects of clozapine and haloperidol.

1 reference

12 December 2020

Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition

1 reference

12 December 2020

Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro

1 reference

12 December 2020

Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care

1 reference

12 December 2020

10.1007/S00213-006-0384-5

Identifiers

DOI

1 reference

6 April 2018

1 reference

6 April 2018